China Merchants China Direct Investments Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Merchants China Direct Investments Limited with three other
companies in this sector in Hong Kong:
Rui Kang Pharmaceutical Group Investments Ltd
sales of 86.57 million Hong Kong Dollars [US$11.09 million]
Uni-Bio Science Group Limited
(146.49 million Hong Kong Dollars [US$18.76 million]
of which 59%
was In-house Biological Pharmaceutical Produ), and
Tianda Pharmaceuticals Ltd
(192.78 million Hong Kong Dollars [US$24.69 million]
of which 100%
was Pharmaceutical and Biotechnology Busines).
During the year ended December of 2016, sales at
China Merchants China Direct Investments Limited were HK$201.80 million (US$25.84 million).
decrease of 36.4%
versus 2015, when the company's sales were HK$317.36 million.
Contributing to the drop in overall sales was the 44.1% decline
in Culture and Media, from HK$171.47 million to HK$95.84 million.
There were also decreases in sales in
Financial Services (down 23.2% to HK$97.14 million)
However, these declines were partially offset by the increase in sales of
Medical and Pharmaceutical (up 48.0% to HK$4.09 million)